Early detection through neonatal screenings allows for prompt intervention, which can significantly reduce the morbidity and mortality associated with certain conditions. These screenings can identify disorders like congenital hypothyroidism, phenylketonuria (PKU), and cystic fibrosis, among others. Early treatment can prevent serious complications, including intellectual disability, growth failure, and even death.
